Stanford University
Showing 19,251-19,300 of 37,123 Results
-
Avinash Londhe
Postdoctoral Scholar, Pathology
BioDr. Avinash Londhe is a postdoctoral researcher in Dr. Katrin Svensson’s lab in the Department of Pathology at Stanford University, where he investigates the complex mechanisms linking cancer, metabolism, and obesity. His research focuses on understanding how orphan peptide hormones regulate metabolic pathways and identifying novel receptor-peptide interactions. Driven by a passion for translational science, Dr. Londhe is committed to translating fundamental discoveries into real-world solutions that improve patient outcomes.
During his doctoral training in Dr. Benoit Boivin’s lab at SUNY Polytechnic Institute, Dr. Londhe gained in-depth expertise in molecular mechanisms underlying metabolic disorders and cancer. His work contributed to the development of therapeutic strategies aimed at metabolic dysfunction. In addition to research, he excelled at managing laboratory operations and mentoring both graduate and undergraduate students, fostering a dynamic and collaborative research environment.
Currently, Dr. Londhe is broadening his research toolkit by integrating bioinformatics, molecular biology, and biophysical techniques into his experimental approaches. His goal is to address critical challenges in cancer metabolism and metabolic diseases through innovative research.
Dr. Londhe aspires to secure a faculty position at a leading university, where he can advance impactful research, mentor emerging scientists, and continue driving scientific innovation. -
Adrienne H. Long, MD, PhD
Instructor, Pediatrics - Hematology & Oncology
BioAdrienne H. Long, MD, PhD is an Instructor and Physician-Scientist in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital, Stanford. Clinically, she completed her MD at Northwestern University, her pediatrics residency at Boston Children’s Hospital, and her oncology fellowship training at Stanford University. Dr. Long sees patients with leukemias/lymphomas, and has a clinical interest in T cell malignancies.
Dr. Long received her PhD in Microbiology/Immunology through a National Institutes of Health (NIH) – Northwestern University partnership, where she worked with Dr. Crystall Mackall to advance CAR T cell therapies. Her influential thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR therapies (Long et al., Nature Medicine, 2015). She continued her research training with Dr. Nicholas Haining at the Dana Farber Cancer Institute during residency and is currently conducting her post-doctoral research with Dr. Mark Davis at Stanford.
Dr. Long’s research interests lie at the intersection of the immune system and cancer therapies. She is currently studying how thymic selection, designed to prevent auto-immunity, may also inhibit anti-tumor immunity in children. She is also interested in how immunotherapies that have revolutionized how we treat cancer can impact the developing pediatric immune system long term. -
Belle Long
Communications Associate, Woods Institute
Current Role at StanfordCommunications Associate, Stanford Woods Institute for the Environment
-
David Long
Postdoctoral Scholar, Physics
Current Research and Scholarly InterestsDavid is a theoretical condensed matter physicist with an expertise in systems far from equilibrium. His research focuses on the dynamics of quantum systems, including many-body dynamics, the process of thermalization in nearly-localized systems, and on robust topological effects in driven systems.
-
Grant Long
Ph.D. Student in Earth and Planetary Sciences, admitted Autumn 2024
BioGrant was born in a small town in Massachusetts and quickly moved to York, Maine, a small beach town. He earned a BSc in Geology from the University of Vermont in 2022. Grant continued with his MSc degree at Stanford University in 2024, focusing on sediment dynamics in Chile.
Grant joined Stanford as an MSc student in the Fall of 2022 and is a part of the Tectonic Geomorphology Lab group led by George Hilley.
Grant’s focus is on landscape evolution in south-central Chile, making comparisons between the modern and glacial-interglacial timescales. -
Jacob Long
Ph.D. Student in Earth and Planetary Sciences, admitted Autumn 2023
Current Research and Scholarly InterestsUsing experimental rock physics and monitoring techniques to study the carbonation process and its impact on reservoir porosity, permeability, and other properties in carbon capture and storage projects.
-
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies the molecular mechanisms of mammalian energy homeostasis. Dr. Long is the recipient of the Alfred P. Sloan Research Fellowship in Chemistry, the Breakthrough Sciences Award from the Ono Pharma Foundation, and the NIDDK Catalyst Award. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Sharon R. Long
William C. Steere, Jr. - Pfizer Inc. Professor of Biological Sciences and Professor, by courtesy, of Biochemistry
Current Research and Scholarly InterestsBiochemistry, genetics and cell biology of plant-bacterial symbiosis
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Dr. Michael T. Longaker
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.
-
Helen Longino
Clarence Irving Lewis Professor of Philosophy, Emerita
Current Research and Scholarly InterestsI am currently pursuing research in several different areas. 1) The concept of interaction in science and philosophy. 2) The epistemology of science, especially social epistemology. 3) The contributions feminist philosophy of science can make to understanding science and sustainability policy in so-called developing countries? 4) How engagement with communities can inform philosophical analysis.
-
Frank M. Longo, MD, PhD
George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.
-
Isaac Longobardi
MD Student with Scholarly Concentration in Clinical Research, expected graduation Spring 2030
BioIsaac Longobardi, from Brooklyn, New York, is pursuing an MD at Stanford School of Medicine. He received his bachelor’s degree in social anthropology from Harvard College. Isaac aspires to transform long-term care services and delivery models for individuals with frailty, chronic illness, and mental and behavioral health conditions and their communities. Between 2022 and 2025, Isaac helped to launch and directed the Moving Forward Nursing Home Quality Coalition—a representative group of nursing home stakeholders working to advance recommendations from “The National Imperative to Improve Nursing Home Quality,” a landmark 2022 report by the National Academies of Sciences, Engineering, and Medicine. Prior to that, he piloted multigenerational living while working as a volunteer youth and community engagement program coordinator at Hebrew SeniorLife, a Boston-based elder services nonprofit. Isaac’s speaking and writing on aging and long-term care include award-winning undergraduate research, a Substack, co-authored health policy articles, and conference presentations.
ORCID: https://orcid.org/0009-0009-8481-571X -
James Longoria, MD
Clinical Associate Professor, Cardiothoracic Surgery
BioDr. Longoria is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Deeply accomplished in all facets of complex adult cardiothoracic procedures, Dr. Longoria is a high-volume surgeon with more than 20 years of experience and an exceptionally low mortality and complication rate.
Dr. Longoria’s surgical experience includes complex mitral valve and tricuspid valve repair, coronary artery bypass grafting, adult congenital repair, as well as procedures for high risk VAD patients. He performs cardiac transplantation, carotid endarterectomy, and implantation of all FDA-approved mechanical circulatory support devices. Additionally, he performs catheter-based valvular procedures (such as transcatheter aortic valve replacement, or TAVR) and open and video-assisted thoracoscopic surgery (VATS) for pulmonary surgical procedures.
He has an applied interest in atrial fibrillation (AFib) and is a nationally recognized expert in the minimally invasive surgical treatment of Atrial Fibrillation (AFib). Dr. Longoria was issued a method patent from the U.S. Patent and Trademark Office for developing the TTMaze (Totally Thoracoscopic) procedure that is central to the Dual Epicardial Endocardial Persistent (DEEP) AFib clinical trial.
Before joining Stanford, Dr. Longoria was the surgical director of cardiac ablation at a prominent AFib center certified by the Society of Chest Pain Centers. He holds patents for a synthetic chord used to connect tissue and for specialized methods he developed to treat cardiac arrhythmias.
At Stanford, Dr. Longoria brings a commitment to patientcentric, personalized care. He is committed to making the experience of surgery as pleasant as possible for his patients. He is also excited for the opportunity to conduct translational research that utilizes the most advanced technology available, in collaboration with colleagues from other disciplines.
For his outcomes and high patient satisfaction ratings, Dr. Longoria has earned awards and recognition, including being named a Top Doctor of Sacramento by his peers for the last five years in a row. He has also been an honoree of the President’s Award for patient satisfaction by the Sutter Independent Physicians.
Dr. Longoria has published articles on genetic variants associated with atrial fibrillation, thoracoscopic left atrial appendage clipping, radiofrequency ablation, and other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, and elsewhere.
He has made numerous presentations on atrial fibrillation surgery and other topics at conferences including the Annual Meeting of the American Association of Thoracic Surgery, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.
Dr. Longoria is a Fellow of the American College of Surgeons and American College of Cardiology. He is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Rhythm Society. -
Chelsea Longwell
Business Development and Marketing Associate for Physical Sciences, Office of Technology Licensing (OTL)
BioPrior to joining Stanford OTL as a Business Development & Marketing Associate, Chelsea earned her PhD in Chemical & Systems Biology from Stanford University. She manages business development and outreach for Stanford technologies in the physical sciences and co-manages the OTL internship program.
-
Billy W Loo Jr, MD PhD FASTRO FACR
Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy clinical specialty is precision targeted radiotherapy of thoracic cancers.
My research is on developing next-generation ultra-rapid radiotherapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiotherapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.
